Last update 20 Mar 2025

Pertussis acellular and DTaP vaccine candidates (Novartis Vaccines)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesOther Diseases
Active Indication-
Inactive Indication
DiphtheriaTetanusWhooping Cough
Originator Organization
Novartis Vaccines & Diagnostics, Inc.
Active Organization-
Inactive Organization
Novartis Vaccines & Diagnostics, Inc.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Pertussis acellular and DTaP vaccine candidates (Novartis Vaccines)
NCT00806195
/ CompletedPhase 3
A Phase 3b, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
100 Clinical Results associated with Pertussis acellular and DTaP vaccine candidates (Novartis Vaccines)
Login to view more data
100 Translational Medicine associated with Pertussis acellular and DTaP vaccine candidates (Novartis Vaccines)
Login to view more data
100 Patents (Medical) associated with Pertussis acellular and DTaP vaccine candidates (Novartis Vaccines)
Login to view more data
100 Deals associated with Pertussis acellular and DTaP vaccine candidates (Novartis Vaccines)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DiphtheriaPhase 1
Belgium
Novartis Vaccines & Diagnostics, Inc.
-
TetanusPhase 1
Belgium
Novartis Vaccines & Diagnostics, Inc.
-
Whooping CoughPhase 1
Belgium
Novartis Vaccines & Diagnostics, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00806195 (CTgov)
Phase 3
Meningitis | Meningococcal Infections
7,744
(MenACWY-CRM197 + Routine Vaccines (Detailed))
hijmlizrim(ewqafbdhxc) = tlrhitzcsh kukcoeplmr (txrqwckxkr, bzfoujkyfp - ubgutrnngx)
View more
-
09 Jul 2013
(Routine Vaccines (Detailed))
hijmlizrim(ewqafbdhxc) = mejasknlzm kukcoeplmr (txrqwckxkr, tgutexippu - ygzdngsrdr)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free